Focus Partners Wealth’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.19M | Buy |
57,177
+6,786
| +13% | +$853K | 0.02% | 569 |
|
|
2025
Q1 | $5.57M | Sell |
50,391
-687
| -1% | -$76K | 0.01% | 592 |
|
|
2024
Q4 | $6.97M | Buy |
51,078
+4,420
| +9% | +$603K | 0.02% | 539 |
|
|
2024
Q3 | $5.38M | Buy |
46,658
+782
| +2% | +$90.1K | 0.02% | 541 |
|
|
2024
Q2 | $6.32M | Buy |
45,876
+397
| +0.9% | +$54.7K | 0.02% | 457 |
|
|
2024
Q1 | $6.27M | Buy |
45,479
+5,058
| +13% | +$698K | 0.05% | 281 |
|
|
2023
Q4 | $5.33M | Buy |
+40,421
| New | +$5.33M | 0.07% | 224 |
|